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Abstract
Background: DNA methylation and the Polycomb repression system are epigenetic mechanisms that play
important roles in maintaining transcriptional repression. Recent evidence suggests that DNA methylation can
attenuate the binding of Polycomb protein components to chromatin and thus plays a role in determining their
genomic targeting. However, whether this role of DNA methylation is important in the context of transcriptional
regulation is unclear.
Results: By genome-wide mapping of the Polycomb Repressive Complex 2-signature histone mark, H3K27me3, in
severely DNA hypomethylated mouse somatic cells, we show that hypomethylation leads to widespread
H3K27me3 redistribution, in a manner that reflects the local DNA methylation status in wild-type cells.
Unexpectedly, we observe striking loss of H3K27me3 and Polycomb Repressive Complex 2 from Polycomb target
gene promoters in DNA hypomethylated cells, including Hox gene clusters. Importantly, we show that many of
these genes become ectopically expressed in DNA hypomethylated cells, consistent with loss of Polycomb-
mediated repression.
Conclusions: An intact DNA methylome is required for appropriate Polycomb-mediated gene repression by
constraining Polycomb Repressive Complex 2 targeting. These observations identify a previously unappreciated role
for DNA methylation in gene regulation and therefore influence our understanding of how this epigenetic
mechanism contributes to normal development and disease.
Keywords: DNA methylation, H3K27me3, Polycomb, PRC2, regulation of transcription
Background
Epigenetic mechanisms, such as DNA methylation and
the Polycomb repressor system, play key roles in main-
taining transcriptional states that are initially established
by transcription factor networks [1,2]. A major challenge
of molecular biology is to understand how epigenetic
mechanisms contribute to the precise temporal and spa-
tial patterns of gene expression that are required for
multicellular life, and how the malfunction of these
mechanisms contributes to human disease.
DNA methylation involves the addition of a methyl
group to position 5 of the pyrimidine ring of the cytosine
base, a reaction catalyzed by a family of DNA methyl-
transferase enzymes [1]. In mammals, DNA methylation
occurs predominantly in the sequence context of 5′-CG-
3′ (CpG) [3,4]. Vertebrates possess a so-called global
methylome, as in most tissues, the majority of cytosines
in the CpG context are found in the methylated state
(5mCpG) [3,5]. The high level of CpG methylation found
in the bulk genome is punctuated by short stretches of
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CpG- and GC-rich sequences, known as CpG islands,
that are normally infrequently methylated and are asso-
ciated with a large proportion of gene promoters [1,3,6].
Despite this general bimodality, DNA methylation pat-
terns are variable between cells of different tissues, and
dynamic during cell differentiation, a feature thought to
contribute to the maintenance of a cell’s transcriptional
state [3-5,7]. At gene promoters that contain sufficient
CpG density, abundant 5mCpG is associated with tran-
scriptional repression [8]. This canonical regulatory role
for DNA methylation contributes to the monoallelic
repression of imprinted genes [9], the stable repression of
large regions of the inactive X-chromosome in female
cells [10], and the tissue-specific repression of a relatively
small number of single copy genes [11,12]. For example,
promoter DNA methylation is utilized in somatic cells to
maintain repression of genes that are expressed in the
germline [13-15]. DNA methylation is able to contribute
to the maintenance of transcription states over time and
cell divisions through two main properties. Firstly, pat-
terns of 5mCpG are copied to the nascent strand during
replication of DNA in a process requiring the mainte-
nance DNA methyltransferase, Dnmt1 [1]. This property
means that patterns of 5mCpG are stable over cell divi-
sion. Secondly, CpG and 5mCpG are differentially bound
by various DNA- and/or chromatin-binding proteins,
many of which have key roles in transcriptional regula-
tion [1,16]. Several of these proteins are either directly or
indirectly involved in further chromatin modification,
leading to the idea that DNA methylation acts as a tem-
plate to direct the establishment or reinforcement of
chromatin states. For example, 5mCpG is specifically
recognized by methyl-CpG-binding proteins, a number
of which are associated with histone deacetylases and
other histone-modifying enzymes [1,17,18]. By contrast,
unmodified CpG is recognized by proteins such as the
histone lysine demethylase Kdm2a, and Cfp1, a protein
that recruits a Setd1 H3K4 methyltransferase complex
[19,20]. Despite advances in this area, our understanding
of how DNA methylation contributes to chromatin
states, and how these states influence gene regulation, is
far from complete.
Polycomb group proteins form multi-protein chromatin-
associated complexes that act as repressors of thousands of
genes, many of which have key functions in embryonic
development and cell-fate decisions [21-24]. The Polycomb
Repressor Complex 2 (PRC2) modifies chromatin structure
by depositing tri-methylation of lysine 27 on histone H3
(H3K27me3) via its catalytic Ezh2/Ezh1 subunit [2,25]. The
H3K27me3 mark is therefore considered a hallmark of
PRC2-mediated repression [2]. Like DNA methylation,
H3K27me3 is propagated through cell divisions, a process
mediated by the ability of the PRC2 complex to bind to
H3K27me3 [26,27]. Evidence suggests that H3K27me3 and
PRC2 lead to transcriptional silencing in multiple ways,
including the recruitment of a subset of Polycomb Repres-
sor Complex 1 (PRC1) protein complexes that recognize
the H3K27me3 mark and induce chromatin compaction
[2,28,29].
In the last few years it has emerged that considerable
cross-talk exists between the DNA methylation and Poly-
comb repression systems, demonstrating that these two
epigenetic mechanisms are intimately linked. Multiple
lines of evidence suggest that DNA methylation is a
negative modulator of PRC2-chromatin interactions.
Firstly, methylation-free CpG islands have been linked to
the recruitment of the PRC2 complex [30-32]. Secondly,
epigenome mapping studies have found a negative corre-
lation between DNA methylation and H3K27me3 pat-
terns in normal [3,5,7,33] and cancer [34,35] tissues,
implying exclusivity of the two marks in mammalian gen-
omes. A similar observation has been made in plant tis-
sues, implying deep conservation of this relationship [36].
It should be noted that, in mammals, a negative correla-
tion between DNA methylation and H3K27me3 is
restricted to relatively CpG-rich regions of the genome,
whereas the two marks co-occupy many CpG-poor
regions [37,38]. The idea of exclusivity is supported by in
vitro experiments demonstrating that PRC2 shows atte-
nuated binding and/or activity on DNA methylated chro-
matin, suggesting that 5mC directly influences PRC2-
chromatin interactions [39,40]. Importantly, when DNA
methylation patterns are experimentally perturbed,
H3K27me3 patterns are altered [32,33,37,39]. For exam-
ple, in mouse embryonic stem cells that are hypomethy-
lated due to lack of DNA methyltransferases, new
domains of H3K27me3 form at genomic regions that are
normally highly DNA methylated in wild-type cells
[22,32]. Also, in hypomethylated mouse embryonic stem
cells, H3K27me3 is reduced at regions where it is nor-
mally abundant in wild-type cells [37].
Collectively, these studies have demonstrated that DNA
methylation plays a role in ensuring correct genomic target-
ing of the PRC2 complex and hence the distribution of the
H3K27me3 mark on chromatin. However, it is unknown if
this function of DNA methylation is important in the con-
text of transcriptional regulation. We reasoned that pertur-
bations in DNA methylation may lead to altered patterns of
transcription due to redistribution of the repressive activity
of the PRC2 complex and the H3K27me3 mark. To test
this hypothesis, we generated genome-wide profiles of
H3K27me3, gene expression and DNA methylation in
severely DNA hypomethylated mouse somatic cells. Our
results uncover an unexpected relationship between DNA
methylation and transcriptional repression by Polycomb.
We suggest that, through facilitating correct PRC2-target-
ing, an intact DNA methylome is required for appropriate
Polycomb-mediated gene repression.
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Results
Mapping epigenetic marks in severely DNA
hypomethylated Dnmt1-/- mouse somatic cells
As a first step to investigate the interplay between DNA
methylation and PRC2 in the context of gene regulation,
we generated maps of DNA methylation, H3K4me3 and
the PRC2-signature H3K27me3 histone mark in cells
where DNA methylation is strongly reduced. We utilized
a previously developed genetic system to induce DNA
hypomethylation, using mouse embryonic fibroblasts
(MEFs) that are homozygous for a hypomorphic allele of
Dnmt1 (Dnmt1n/n), the gene encoding the major mainte-
nance DNA methyltransferase [12,41]. In addition to a
Dnmt1 mutation, these cells are homozygous null for
trp53, encoding the p53 protein, and are therefore com-
pared to trp53-/- cells as control (herein referred to as
Dnmt1+/+ and Dnmt1-/- MEFs for simplicity) [12]. The
advantage of this system is that Dnmt1-/- MEFs are
severely hypomethylated yet viable in culture [12]. We
quantified global levels of the 5mC base by performing
high performance liquid chromatography (HPLC) (Figure
1A). This assay confirmed that Dnmt1-/- MEFs are
severely hypomethylated at the global level, possessing
<20% residual 5mC compared to controls (Figure 1A; P
<0.001 by t-test). We generated single-nucleotide resolu-
tion maps of DNA methylation from Dnmt1+/+ and
Dnmt1-/- MEFs by extended-coverage reduced-represen-
tation bisulfite sequencing (RRBS) (see Materials and
methods). Using this method we quantified the methyla-
tion level of >1.7 million CpGs that had a sequencing
depth of at least 10 reads in each condition (the median
depth was >26 reads among these CpGs in each condi-
tion). In Dnmt1+/+ MEFs, the expected bimodal distribu-
tion of CpG methylation was observed, with most CpGs
having either very high or very low levels of DNA methy-
lation (Figure 1B). In Dnmt1-/- MEFs, CpG methylation
was strongly reduced consistent with widespread hypo-
methylation (Figure 1B).
We next examined the effect of DNA hypomethylation
on H3K27me3 and H3K4me3 patterns at gene promoter
regions. We initially used native chromatin-immunopreci-
pitation (ChIP) [28,42] coupled to a microarray that repre-
sents over 24,000 RefSeq gene promoters (ChIP-chip
approach). We validated the accuracy of this approach
using real-time quantitative PCR (ChIP-qPCR) for nine
selected promoter regions (Figure S1 in Additional file 1).
Enrichments using these two methods were highly similar
(H3K27me3, R2 = 0.826, P <0.001; H3K4me3, R2 = 0.876,
P <0.001). Using the ChIP-chip data, we identified promo-
ters that were differentially marked by either histone mod-
ification in hypomethylated cells by selecting those where
the q-value (t-test P-value corrected for multiple testing
by the Benjamini-Hochberg method [43]) was less than
0.05 and the difference between the mean promoter
enrichment (expressed as the log2 ratio of immunoprecipi-
tate (IP) signal to input (INP) signal - log2(IP/INP)) across
conditions was greater than 0.5 in either direction (Figure
1C,D). We observed a large number of promoters that
showed differential H3K27me3 or H3K4me3 in hypo-
methylated cells, consistent with the notion that DNA
methylation is an important modulator of these histone
marks. The data for all analyzed promoter regions is sup-
plied as a supplementary file (Additional file 2). Surpris-
ingly, we observed 1,453 promoter regions with
significantly lower H3K27me3 in Dnmt1-/- compared to
Dnmt1+/+ MEFs (’H3K27me3 down’ promoters) (Figure
1C). We observed that 81 promoters showed the opposite
trend, with increased H3K27me3 in Dnmt1-/- MEFs
(’H3K27me3 up’ promoters) (Figure 1C). For H3K4me3,
236 promoters were found to have increased enrichment
in Dnmt1-/- MEFs (’H3K4me3 up’ promoters) whereas 31
showed lower enrichment (’H3K4me3 down’ promoters)
(Figure 1D). Importantly, immunoblotting showed that
there was no global decrease in the H3K27me3 mark or
the protein levels of the core PRC2 subunits in hypo-
methylated cells, suggesting that the observed changes in
H3K27me3 distribution were not due to loss of PRC2
function in these cells (Figure 1E,F). In fact, the global
levels of H3K27me3 and H3K4me3 appeared to be
increased in Dnmt1-/- relative to Dnmt1+/+ MEFs, consis-
tent with DNA methylation having an inhibitory effect on
the deposition of these histone marks [19,39].
Because we observed a large number of promoters
that lose H3K27me3 in Dnmt1-/- MEFs (Figure 1C),
only a small number of promoters that gain this mark
(Figure 1C), and no decrease in global H3K27me3 (Fig-
ure 1E), we hypothesized that H3K27me3 increases at
regions outside of gene promoters in hypomethylated
cells. Indeed, it has recently been observed that, in
embryonic stem (ES) cells deficient for DNA methyl-
transferases, increased H3K27me3 occurs over large
domains [32,37]. To address this possibility, we mapped
the H3K27me3 and H3K4me3 histone marks genome-
wide using ChIP followed by massively parallel sequen-
cing (ChIP-seq) from Dnmt1+/+ and Dnmt1-/- MEFs.
This assay replicated the changes observed at promoters
by ChIP-chip, and in addition identified regions that
showed differential enrichment for H3K27me3 between
Dnmt1-/- and Dnmt1+/+ MEFs in a genome-wide man-
ner (see Materials and methods). We observed increased
H3K27me3 in hypomethylated cells at many regions
outside of gene promoters, consistent with our predic-
tion. Genomic regions found to differ in H3K27me3
between the two cell lines are provided as a supplemen-
tary file (100 kb genomic windows: Additional file 3; 1
kb genomic windows: Additional file 4). Two intergenic
regions are shown in Figure S2 in Additional file 1,
where increased H3K27me3 was observed over large
Reddington et al. Genome Biology 2013, 14:R25
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domains in Dnmt1-/- MEFs compared to low enrichments
in Dnmt1+/+ MEFs. We used ChIP-qPCR to confirm the
observed increased H3K27me3 at these regions in
Dnmt1-/- MEFs (Figure S2C in Additional file 1).
As DNA methylation is thought to have a negative effect
on the binding or activity of the PRC2 complex on
chromatin [39,40], we reasoned that if the observed
changes in H3K27me3 occupancy in DNA hypomethy-
lated somatic cells are directly caused by changes in DNA
methylation, then they should reflect local DNA methyla-
tion levels. For example, H3K27me3 up regions would be
expected to be highly DNA methylated in Dnmt1+/+ cells,
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where DNA methylation inhibits H3K27me3 deposition,
and hypomethylated in Dnmt1+/+ cells, where H3K27me3
is increased. Conversely, H3K27me3 down regions may be
associated with low levels of DNA methylation in Dnmt1
+/+ cells where they are enriched for H3K27me3. We
tested this hypothesis by examining DNA methylation
levels in RRBS data of CpGs within regions that showed
increased or decreased H3K27me3 in DNA hypomethy-
lated cells by ChIP-seq. In Dnmt1+/+ MEFs, all CpGs
showed the expected bimodal distribution of DNA methy-
lation levels (Figure 2A upper). CpGs within H3K27me3
down regions had low levels of methylation, whereas
CpGs within H3K27me3 up regions had high levels of
DNA methylation (Figure 2A upper). In Dnmt1-/- cells, the
DNA methylation level of CpGs in all of these categories
was decreased (Figure 2A lower). The same associations
between H3K27me3 changes and DNA methylation levels
in Dnmt1+/+ MEFs were observed when DNA methylation
was mapped using an independent method, HpaII tiny
fragment enrichment by ligation-mediated PCR (HELP)
followed by tag sequencing (HELP-tag-seq) (Figure S3 in
Additional file 1). We performed bisulfite sequencing of
selected H3K27me3 down and up regions to confirm that
they were associated with low and high levels of DNA
methylation, respectively, in wild-type cells (Figure 2B).
These observations support the notion that DNA
methylation is an important modulator of H3K27me3 pat-
terns, and demonstrate that severe DNA hypomethylation
leads to altered distribution of H3K27me3 in mouse
somatic cells, suggesting that this is not an exclusive fea-
ture of hypomethylated mouse ES cells. Importantly, this
map of H3K27me3 changes in DNA hypomethylated cells
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could be used as a starting point to investigate the inter-
play between DNA methylation and PRC2 in the context
of transcriptional regulation.
An intact DNA methylome is required for efficient
binding of PRC2 to its normal target gene promoters
including Homeobox gene clusters
The most surprising facet of H3K27me3 redistribution in
hypomethylated somatic cells was that this mark was lost
from a large number of gene promoters (Figure 1C). We
reasoned that, due to increased binding of the PRC2 com-
plex to numerous newly uncovered sites within a hypo-
methylated genome, the complex may be diluted from its
normal targets. We looked for a relationship between pro-
moter H3K27me3 enrichment in Dnmt1+/+ MEFs and
H3K27me3 difference between Dnmt1+/+ and Dnmt1-/-
MEFs, and found that they were negatively correlated (Fig-
ure 3A; R2 = 0.487, P <10-15). Thus, promoters that repre-
sented normal Polycomb targets in Dnmt1+/+ MEFs lost
H3K27me3 in Dnmt1-/- MEFs. For example, most promo-
ters from the four Hox gene clusters, classic Polycomb tar-
get genes, exhibited striking loss of H3K27me3 upon
hypomethylation (Figure 3A, red points). We performed a
pile-up of sequence reads from ChIP-seq at genes that
were highly marked by H3K27me3 in Dnmt1+/+ MEFs
(the top 10% of genes measured by ChIP-chip, Figure 3B).
As expected, these genes showed enrichment for
H3K27me3 reads in Dnmt1+/+ MEFs, particularly in their
upstream regions. In Dnmt1-/- MEFs, the H3K27me3 pro-
file was lower across the whole region analyzed, consistent
with loss of PRC2 function at its normal target genes in
Dnmt1-/- MEFs (Figure 3B). We tested for enrichment in
Gene Ontology terms among H3K27me3 down genes and
found that they were highly enriched for functions in cell
development, embryonic development and cell-fate com-
mitment, reflecting terms that have previously been asso-
ciated with Polycomb target genes (Figure 3C) [22-24,44].
Indeed, when H3K27me3 target genes were used as a
background for Gene Ontology enrichment analysis of
H3K27me3 down genes, no significant terms were found.
Together, these results suggest that, in hypomethylated
cells, H3K27me3 is not lost from a specific set of Poly-
comb target genes but rather it is generally decreased at
its normal target promoters, consistent with a ‘dilution’
hypothesis.
We performed ChIP-qPCR using primers designed for
the promoter regions of selected H3K27me3 down genes,
including Hox genes, to validate the H3K27me3 loss in
Dnmt1-/- MEFs that was observed by ChIP-chip. The
Actb (negative) and Chdh (positive) promoters were
included as controls for the assay. All of the selected
H3K27me3 down promoters showed striking loss of
H3K27me3 enrichment in Dnmt1-/- MEFs, down to levels
comparable to the negative control Actb promoter and
non-specific immunoglobulin G (IgG) immunoprecipita-
tion (Figure 3D). Of note, several adjacent HoxC genes
were found to have lost H3K27me3 enrichment in
Dnmt1-/- MEFs (Figure 3D). To determine whether
H3K27me3 loss in Dnmt1-/- MEFs was concomitant with
loss of PRC2 binding to these gene promoters, we per-
formed cross-linked ChIP for the PRC2 histone methyl-
transferase Ezh2 (Figure 3E). A marked reduction of
Ezh2 binding at these gene promoters was observed in
Dnmt1-/- MEFs, consistent with loss of PRC2 binding
(Figure 3E).
De-repression of Polycomb target genes upon genome-
wide loss of DNA methylation
As PRC2 and its associated histone methyltransferase activ-
ity are known to have key roles in transcriptional repres-
sion, we next asked if loss of H3K27me3 and PRC2
binding in Dnmt1-/- MEFs is associated with ectopic gene
expression. We generated transcriptome profiles of Dnmt1
+/+ and Dnmt1-/- MEFs using strand-specific mRNA-seq
and gene expression microarrays. Using these methods,
Dnmt1-/- MEFs showed the expected de-repression of
genes known to rely on DNA methylation for repression,
such as imprinted genes (data not shown). The Actb locus
is shown in Figure 4A as a control as it was expected to be
positive for H3K4me3 and expressed in both conditions
and negative for H3K27me3. We first examined Hox gene
clusters as they represent classic Polycomb target genes,
are known to require PRC2 and/or H3K27me3 for their
normal regulation [22,24], and were identified in our ChIP-
chip as showing loss of H3K27me3 in Dnmt1-/- MEFs. In
Dnmt1+/+ MEFs, the HoxC cluster was covered by a large
block of H3K27me3, as previously reported for MEFs [45],
whereas, strikingly, this block was absent in Dnmt1-/-
MEFs (Figure 4B). In Dnmt1+/+ MEFs, RNA was detected
on the sense strand in the region from Hoxc4 to Hoxc10
genes, whereas the Hoxc11 to Hoxc13 genes were silent
(Figure 4B). In Dnmt1-/- MEFs, concomitant with the loss
of H3K27me3, RNA was detected on the sense strand
from all genes in the cluster. Similar transcriptional effects
at Hox gene clusters have been observed previously when
Polycomb components are mutated in MEFs, consistent
with the hypothesis that Hox gene mis-regulation in
Dnmt1-/- MEFs is caused by loss of Polycomb-mediated
repression [46]. In addition to the de-repression of the
Hoxc11 to Hoxc13 genes in Dnmt1-/- MEFs, RNA was
detected from intergenic regions and from the antisense
strand. H3K4me3 was increased across much of the HoxC
cluster in Dnmt1-/- MEFs, particularly across the region of
the cluster that becomes strongly de-repressed (Figure 4B).
A similar effect was observed at the HoxA and HoxD clus-
ters, including loss of H3K27me3 from a large genomic
region and de-repression of Hox genes within the normally
silent portion of the cluster (Figure 4C,D). The HoxB
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cluster showed loss of H3K27me3 across a large domain
but did not show upregulation of RNA or H3K4me3 in
Dnmt1-/- MEFs (data not shown). Importantly, we have
already shown that the promoters of the studied Hox
genes, and H3K27me3 down regions in general, are asso-
ciated with low levels of DNA methylation in Dnmt1+/+
MEFs, suggesting that their de-repression in Dnmt1-/-
MEFs is not due to loss of canonical promoter DNA
methylation-mediated repression (Figure 2). Instead, these
observations are consistent with loss of PRC2-mediated
repression at Hox genes in Dnmt1-/- MEFs.
As H3K27me3 is lost from a large number of gene pro-
moters in Dnmt1-/- MEFs, we investigated differential gene
expression in these cells in a global manner using mRNA-
seq and expression microarray. Using both methods, we
observed that H3K27me3 down genes are associated with
increased expression in Dnmt1-/- MEFs (Figure 5A,B;
P <0.001 by Wilcoxon rank sum test). We performed
RT-qPCR to confirm upregulation at the mRNA level of
selected H3K27me3 down genes in Dnmt1-/- MEFs, includ-
ing Hox genes (Figure S4 in Additional file 1). Using our
promoter ChIP-chip data, we observed that H3K27me3
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down genes were also associated with increased promoter
H3K4me3 in Dnmt1-/- MEFs, consistent with increased
transcriptional initiation (Figure 5C; P <0.001 by Wilcoxon
rank sum test). By overlapping H3K27me3 down genes
and >2-fold upregulated genes (by mRNA-seq), we
observed that 185 genes fell into both categories, a far
greater overlap than would be expected by chance (Figure
5D; P <0.001 estimated by hyper-geometric testing). This
represents around a third of the increased expression
observed in hypomethylated cells, suggesting that contri-
buting to Polycomb-mediated repression is a major func-
tion for DNA methylation in gene regulation. This also
shows that only a proportion of genes that lose promoter
H3K27me3 in DNA hypomethylated cells are transcrip-
tionally upregulated, highlighting the involvement of other
factors (for example, the presence or absence of certain
transcription factors) in their regulation.
We wondered whether the increased H3K27me3 that is
observed at certain genomic regions in DNA hypomethy-
lated cells is associated with de novo repression of tran-
scription. DNA methylation is high within many gene
body regions and has been suggested to correlate posi-
tively with transcription and therefore may act to inhibit
PRC2 binding [3,4,39]. We identified large genomic win-
dows (100 kb) that showed increased or decreased
H3K27me3 in Dnmt1-/- MEFs by ChIP-seq (see Materials
and methods) and examined the expression of genes
within these windows using mRNA-seq. Genes within
large H3K27me3 down windows were associated with
increased expression in Dnmt1-/- relative to Dnmt1+/+
MEFs, consistent with our observations at gene promoter
regions (Figure S5A in Additional file 1). Conversely,
genes within large H3K27me3 up windows were asso-
ciated with decreased expression in Dnmt1-/- MEFs, con-
sistent with increased PRC2-mediated repression at these
genes in DNA hypomethylated cells (Figure S5A in Addi-
tional file 1). We chose two genes, Pcdhb18 and Pcdhb20,
that we had already shown by bisulfite sequencing to be
associated with dense DNA methylation within an intra-
genic CpG island in Dnmt1+/+ MEFs (Figure 2B). We per-
formed H3K27me3 ChIP-qPCR for each intragenic region,
which showed that they were associated with increased
H3K27me3 in Dnmt1-/- MEFs when the DNA methylation
is removed (Figure S5B in Additional file 1). We showed
by qRT-PCR that the increased H3K27me3 at these genes
was associated with decreased mRNA expression in
Dnmt1-/- MEFs (Figure S5C in Additional file 1).
These findings suggest that altered H3K27me3 distri-
bution upon loss of DNA methylation is associated with
changes in gene expression. Given that DNA methylation
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can directly modulate H3K27me3 patterns [39], and
H3K27me3 and PRC2 are known to induce transcrip-
tional repression, it is likely that redistribution of the
repressive activity of PRC2 accounts for many of the
observed transcriptional changes in DNA hypomethy-
lated cells. However, it is not possible at this point to say
that redistribution of H3K27me3 is the sole driver of the
observed expression changes, as other factors are likely
to contribute to gene expression changes in Dnmt1-/-
MEFs.
Independent methods of inducing DNA methylation loss
result in H3K237me3 redistribution and de-repression of
Polycomb target genes
To validate our findings using Dnmt1-/- MEFs, we used an
independent method to induce DNA hypomethylation. We
cultured Dnmt1+/+ MEFs in the presence of a small mole-
cule inhibitor of DNA methylation, 5-aza-2′-deoxycytidine
(5-aza-dC), for 72 hours. This caused >50% loss of 5mC as
measured globally by HPLC (Figure 6A, P <0.001 by t-test).
ChIP-qPCR revealed that, in 5-aza-dC-treated cells,
H3K27me3 enrichment was reduced at promoter regions
that also lose this mark in Dnmt1-/- MEFs, whereas it was
not reduced at the positive control Chdh promoter (Figure
6B). 5-aza-dC treatment also resulted in increased
H3K27me3 at selected regions that gain H3K27me3 in
Dnmt1-/- MEFs (Figure S6 in Additional file 1). It should
be noted that the observed changes in H3K27me3 occu-
pancy upon 5-aza-dC treatment were smaller in magnitude
than those observed in Dnmt1-/- MEFs, perhaps owing to
the differences in the extent of DNA hypomethylation
observed using these two methods and the short time per-
iod employed in the 5-aza-dC experiment. In order to
examine gene expression changes induced by 5-aza-dC
treatment of Dnmt1+/+ MEFs, we performed expression
microarrays. We examined the expression of genes that
were associated with both decreased promoter H3K27me3
(H3K27me3 down genes) and increased expression (>1.5
fold) in Dnmt1-/- MEFs. Importantly, these genes were also
associated with increased expression upon demethylation
of Dnmt1+/+ MEFs with 5-aza-dC (Figure 6C). Of note, we
have already shown that these genes are associated with
low levels of promoter DNA methylation in Dnmt1+/+
MEFs (Figure 2). We performed RT-qPCR in Dnmt1+/+
MEFs treated with 5-aza-dC to validate the upregulation of
these genes that was observed by microarray (Figure 6E).
We also examined the expression of genes that were within
100 kb windows of the genome that show increased
H3K27me3 in Dnmt1-/- MEFs, which we showed were on
average downregulated in Dnmt1-/- MEFs (Figure S5A in
Additional file 1). Importantly, upon treatment of Dnmt1
+/+ MEFs with 5-aza-dC, these genes were also down-
regulated on average (Figure 6D). We showed that upon 5-
aza-dC treatment, the intragenic regions of the Pcdhb18
and Pcdhb20 genes were associated with increased
H3K27me3 (Figure S6A in Additional file 1), and these
genes were downregulated at the mRNA level (Figure S6B
in Additional file 1). Importantly, this experiment demon-
strated that inducing DNA hypomethylation using an inde-
pendent experimental method leads to H3K27me3
redistribution and gene expression changes that are consis-
tent with those observed in Dnmt1-/- MEFs.
To further validate our observations we used a third
independent experimental method to induce DNA hypo-
methylation. We generated Dnmt1+/+ MEFs that stably
expressed a short hairpin RNA against Dnmt1 (sh-Dnmt1
cells) [47]. We generated three independent cell lines
expressing the Dnmt1 short hairpin RNA and three using
a control plasmid. We confirmed by qRT-PCR that
Dnmt1 mRNA was depleted in sh-Dnmt1 cells (Figure
S7A in Additional file 1), and by HPLC that the genome
was hypomethylated (Figure S7B in Additional file 1). We
measured the expression of selected H3K27me3 down and
H3K27me3 up genes in sh-Dnmt1 cells. Consistent with
our observations using other DNA hypomethylated
systems, H3K27me3 down genes were upregulated in
sh-Dnmt1 cells (Figure S7C in Additional file 1) and
H3K27me3 up genes were downregulated (Figure S7D in
Additional file 1). This experiment showed that our obser-
vations made using Dnmt1-/- MEFs were consistent across
multiple methods for inducing DNA methylation loss of
cells in culture.
To look for an effect of DNA hypomethylation on Poly-
comb target gene expression in vivo, we examined the
expression of an H3K27me3 gene set in mouse embryos
homozygous for a point mutation in Dnmt1 (referred to as
Dnmt1PM allele) [48]. This point mutation causes instabil-
ity of the Dnmt1 protein and therefore results in DNA
hypomethylation and embryonic lethality when homozy-
gous [48]. We analyzed gene expression in Dnmt1+/PM
and Dnmt1PM/PM embryos at 7.5 dpc (days post coitum),
as at later stages severe developmental defects become
apparent in homozygotes (Figure S8A in Additional file 1)
[48]. We observed modest but consistent increases in
expression of the tested Polycomb target genes in
Dnmt1PM/PM embryos at 7.5 dpc, although variation
between embryos was large at this developmental stage
(Figure S8B in Additional file 1). This suggests that this
mechanism may be operating in vivo during mammalian
embryonic development.
Discussion
We have uncovered an unexpected link between DNA
methylation and PRC2-mediated gene repression. An
intact DNA methylome is required to restrict PRC2-
function to its normal gene targets. Where DNA methy-
lation levels are reduced in somatic cells, either geneti-
cally or by pharmacological inhibition, many Polycomb
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target genes lose their association with PRC2 and
H3K27me3, and become ectopically expressed.
How Polycomb complexes are targeted to specific
regions of the mammalian genome is a major question
[44]. Here, we followed multiple lines of evidence that
implicated DNA methylation as a player in this process. In
severely DNA hypomethylated mouse somatic cells, we
found that H3K27me3 was redistributed in a manner that
reflected the DNA methylation pattern in wild-type cells.
Increased H3K27me3 occurred at many regions of the gen-
ome that are normally highly DNA methylated, consistent
with the idea that DNA methylation is capable of attenuat-
ing PRC2 binding in certain genomic contexts. This finding
is consistent with recently published studies that investigate
patterns of H3K27me3 in hypomethylated mouse ES cells,
but also suggests that this may be a function of the DNA
methylome in lineage committed, in addition to pluripo-
tent, cell types [32,37]. Importantly, we also observed
decreased H3K27me3 at a large number of normal Poly-
comb targets that are associated with low-level DNA
methylation in wild-type cells. We suggest the following
model to account for both features of H3K27me3 redistri-
bution in hypomethylated cells (Figure 7). Upon hypo-
methylation, DNA methylation-mediated repression of
PRC2 binding is lost, allowing increased PRC2 binding and
H3K27me3 modification at inappropriate genomic loci.
These regions are associated with high levels of DNA
methylation in wild-type cells where DNA methylation
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inhibits PRC2 binding. We suggest that this leads to a dilu-
tion of PRC2 away from its normal targets (Figure 7). This
idea is supported by recent work using hypomethylated ES
cells, where decreased H3K27me3 was observed at regions
that are marked by discrete peaks of H3K27me3 in wild-
type cells, and new domains of H3K27me3 are formed at
ectopic locations [37]. This model makes the assumption
that the amount of the PRC2 complex is limiting in these
cells. We speculate that the cell must maintain appropriate
levels of this complex to avoid the aberrant repression of
transcription at non-target loci. This model explains the
general loss of H3K27me3 that we observed from its nor-
mal target promoters, and the strong association between
DNA methylation patterns and H3K27me3 changes upon
hypomethylation. Further work will be required to test this
hypothesis and to further define the mechanism behind the
H3K27me3 redistribution observed upon loss of DNA
methylation, and its consequences for gene regulation [49].
The molecular mechanism behind DNA methylation-
mediated attenuation of PRC2-chromatin interactions is
not yet known. In vitro experiments using reconstituted
PRC2 and chromatin suggest that one or more PRC2 com-
ponents are capable of directly differentiating CpG from
5mCpG [39]. PRC2 is thought to bind to chromatin
through several DNA and histone interactions [2]. DNA
methylation may be interpreted by one or more individual
subunits of PRC2, or by the complex as a whole in response
to a structural change of chromatin induced by DNA
methylation. Several PRC2 components contain zinc finger
domains that could potentially mediate this effect, as the
PRC2 target genes repressed
Normal Unmethylated CpG
Methylated CpG
H3K27me3
PRC2
Some genes are sensitive 
to PRC2 loss and are 
de-repressed. This could be
due for example to the
presence of necessary 
transcription factors etc
DNA hypomethylation
PRC2
Increased PRC2 binding
at newly uncovered loci
These sites are highly 
methylated in wildtype cells
where DNA methylation 
inhibits PRC2 binding
Numerous increased binding
thoughout the hypomethyated genome
leads to reduced PRC2 binding at
normal targets due to dilution
These sites are low level
methylated in wildtype cells
1 2 3
Figure 7 A model for de-repression of Polycomb target genes upon loss of DNA methylation. In normal cells, PRC2 is targeted to
chromatin in a process that involves unmethylated stretches of DNA, such as CpG islands (PRC2 targeting is indicated by green arrows). DNA
methylation has a negative effect on PRC2 binding to chromatin and so constrains PRC2 targeting. When global DNA methylation levels are
reduced, PRC2 binding and H3K27me3 increase at numerous additional genomic loci leading to a dilution of available PRC2 from its normal
targets. Note that only loci that are somehow permissive to PRC2 binding show increased H3K27me3 in hypomethylated cells. Reduced PRC2
binding to its normal target promoters results in loss of transcriptional repression. PRC2, Polycomb Repressive Complex 2.
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DNA binding of certain zinc finger domains, such as
CXXC domains, are directly inhibited by DNA methylation
[2,19,20].
We did not observe increased H3K27me3 in hypo-
methylated cells at all regions of the genome that are
highly DNA methylated in normal cells. This would be
expected to occur if the DNA methylation pattern was
the sole determinant of H3K27me3 targeting. Rather,
this observation is further proof that DNA methylation
is merely one of multiple signals that the cell uses to
correctly position the H3K27me3 mark in the genome.
This is consistent with other studies demonstrating the
importance of sequence-specific DNA-binding proteins
[44], transcription [31], non-coding RNA [50] and other
chromatin features [51] in the targeting of H3K27me3.
The final distribution of H3K27me3 is therefore likely
the result of the concerted action of these multiple
mechanisms. Future studies, taking into account DNA
sequence, RNA, and epigenetic modulators of PRC2-
binding will help to advance our understanding of this
complex problem.
Importantly, we observed that loss of promoter
H3K27me3 in DNA hypomethylated somatic cells was
associated with transcriptional activation, consistent
with a loss of Polycomb-mediated repression. This sug-
gests that an intact DNA methylome is indirectly
required for the normal repression of PRC2-target
genes. This unexpected finding significantly widens the
scope for genes that require DNA methylation for their
repression. Owing to their low level of promoter DNA
methylation, these genes would not normally be asso-
ciated with repression that involves DNA methylation.
Many of these genes are classic Polycomb targets, such
as the Hox genes, and have known functions in embryo-
nic development and cell-fate specification. In fact, Hox
gene regulation has been previously linked to DNA
methylation, but the underlying role of DNA methyla-
tion in this process has remained unclear. Firstly, mice
with hypomorphic mutations in the DNA methyltrans-
ferase gene Dnmt3b display homeotic transformations of
the posterior axis, concomitant with de-repression of
certain HoxA genes [14]. Secondly, loss of the Lsh pro-
tein leads to DNA hypomethylation and mis-expression
of certain Hox genes in mouse embryos and cell lines
[52]. The findings presented in our study provide an
alternative explanation for Hox gene de-repression upon
hypomethylation, even when the gene of interest is not
associated with a highly DNA methylated promoter. It
should be noted that our knowledge of DNA methyla-
tion patterns within Hox clusters is incomplete. Hox
cluster DNA methylation appears to vary in a complex
tissue- and cluster-specific manner, but the CpG-rich
regions associated with Hox gene promoters appear to
remain in an unmethylated state in most tissues studied
[3-6]. Indeed, in our study, we observed that the CpG-
rich promoters of the Hox genes studied contained low
levels of DNA methylation in MEFs, suggesting that their
de-repression was not caused by loss of promoter DNA
methylation. However, at this point we cannot completely
exclude a role for promoter DNA methylation in the
repression of these genes. We also note that Hox gene
expression patterns in fibroblasts are dependent on their
anatomic location, and that these patterns are maintained
when fibroblasts are grown in culture [53]. Importantly,
we have shown that DNA hypomethylation induced in
Dnmt1+/+ MEFs results in de-repression of Hox genes.
This experiment compares the same starting population of
cells, excluding the possibility that the observed gene
expression differences are due to differential anatomic ori-
gin of the samples. However, we note that we cannot for-
mally exclude the possibility that the severe mis-
expression of Hox genes observed in Dnmt1-/- MEFs was
further enhanced by a potential differential anatomic ori-
gin of these cells. Nevertheless, our data demonstrate that
loss of DNA methylation by itself is sufficient to induce
de-repression of Hox genes.
Our observations could also offer an explanation for the
enigmatic de-repression of PRC2-target developmental
genes in cells of patients with immunodeficiency-centro-
meric instability-facial abnormalities (ICF) syndrome, a dis-
order frequently caused by mutation in DNMT3B [54]. A
subset of PRC2-target genes that are associated with CpG-
rich DNA methylation-free promoters were observed to be
upregulated in cells of patients with ICF syndrome relative
to controls [54]. It is feasible that DNMT3B-mutation
induced DNA hypomethylation elsewhere in the genome
drives reduction in PRC2 and H3K27me3 occupancy at
these gene promoters, resulting in leaky repression. Our
observations may also influence our understanding of the
phenotypes of Dnmt1 loss in embryonic development and
in multipotent stem cell populations, such as hematopoietic
stem cells, where the phenotypes observed are compatible
with mis-regulation of cell-fate specifying genes [41,55-57].
The findings presented in this study, along with others,
demonstrate that DNA methylation is a major factor in
determining PRC2 targeting in mouse cells. Different
aspects of the DNA methylome appear to have been lost
during the evolution of certain branches of organisms
[58,59]. Some, such as the fruit fly Drosophila melanogaster,
have lost CpG methylation entirely [59] and, in this organ-
ism, DNA-binding transcription factors play an important
role in Polycomb targeting by binding to sequence elements
called Polycomb response elements (PREs) [44]. The search
for PREs in mammals so far has yielded few results [44]. It
is interesting to speculate that without the restrictive activ-
ity of DNA methylation, Drosophila may rely more heavily
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on a PRE approach for Polycomb targeting. In support of
this speculation, mapping of Polycomb components by
ChIP in Drosophila has shown that, with the exception of
Pc, which binds H3K27me3, Polycomb components are
bound in punctate regions at PREs [44]. This is in contrast
to mammals where PRC2 components are bound in more
broad domains that are better associated with H3K27me3
domains [44]. We speculate that these differences
could have arisen as a need to restrict PRC2 binding in -
Drosophila in the absence of CpG methylation.
Both DNA methylation and H3K27me3 patterns are
dynamic during cell differentiation [3-5,7,45] and it
remains to be investigated whether DNA methylation
dynamics play a direct role in determining changes in
H3K27me3 patterns upon lineage commitment. In this
respect, loss of DNA methylation from specific loci during
ES cell differentiation has been correlated with increased
H3K27me3 [7]. A similar hypothesis could be addressed in
various cancers, where dramatic alterations in DNA methy-
lation are often observed (for example, [60]). Frequent
observations in cancers are DNA hypomethylation of large
genomic domains and hypermethylation of CpG islands. It
will be intriguing to investigate the effect of DNA methyla-
tion redistribution on PRC2 targeting in cancer cells, and
its effect on gene expression. Indeed, new domains of
H3K27me3 have been observed in breast cancer cell lines
in regions that become DNA hypomethylated [35]. Also,
loss of H3K27me3 has been observed at promoters that
become DNA hypermethylated in a prostate cancer cell
line, consistent with the idea that DNA methylation
changes can drive alteration of PRC2-chromatin interac-
tions in cancer [34].
Conclusions
We suggest that the DNA methylome has an unexpected
role in the repression of Polycomb target genes, as it is
essential for appropriate targeting of PRC2 and the
H3K27me3 histone modification in mouse somatic cells.
These findings significantly advance our understanding
of how DNA methylation influences chromatin states
and highlights the diverse ways that this epigenetic mark
contributes to genome regulation.
Materials and methods
Cell lines and mouse strains
Dnmt1+/+ and Dnmt1-/- MEFs were a gift from Howard
Cedar and their derivation and culture conditions have
been previously described [12]. For treatment of Dnmt1+/+
MEFs with 5-aza-dC, dimethyl sulfoxide vehicle control or
0.5 µM 5-aza-dC (Sigma-Aldrich, St Louis, MO, USA) was
added to the culture media for 72 h, and the media was
changed daily with fresh drug added. Stable knockdown of
Dnmt1 was achieved by lentiviral transduction of a vector
containing a short hairpin RNA against Dnmt1 [47] in tri-
plicate into Dnmt1+/+ MEFs, followed by selection using
Blasticidin (Invitrogen, Life Technologies, Carlsbad, CA,
USA). The Dnmt1PM allele has been previously described
as the MommeD2 allele [48].
Chromatin-immunoprecipitation analyses
Detailed protocols are supplied for native and cross-
linked ChIP in Text S1 in Additional file 1. Per immuno-
precipitation, we used 10 µg of the following antibodies:
aH3K27me3 (Merck-Millipore, Billerica, MA, USA; cat:
07-449); aH3K4me3 (Merck-Millipore; cat: 07-473); non-
specific rabbit IgG (Santa Cruz Biotechnology Inc, Dallas,
TX, USA; cat: sc-2027); aEzh2 (Merck-Millipore; cat:
17-662); non-specific mouse IgG (Santa Cruz Biotechnol-
ogy Inc; cat: sc-2025). Region-specific primers used for
ChIP-qPCR are shown in Table S1 in Additional file 1.
For ChIP-chip, input and immunoprecipitated DNA
from three replicates was amplified using the WGA2
whole genome amplification kit (Sigma-Aldrich). For
promoter arrays, amplified DNA was labeled and hybri-
dized to Mouse ChIP-chip 3x720K RefSeq Promoter
Arrays (Roche NimbleGen Inc, Madison, WI, USA) by
the Microarray Core Facility of the VU University Medi-
cal Center, Amsterdam, The Netherlands. Data were
extracted using NimbleScan v2.5 (Roche NimbleGen).
ChIP-seq libraries were sequenced using single-end
35 bp sequencing on an Illumina Genome Analyser II
(performed by Ambry Genetics, Aliso Viejo, CA, USA).
The number of reads that were successfully mapped to
the genome and used in the analysis is shown in Table S2
in Additional file 1.
Western blots
Detailed protocols are supplied for protein extract pro-
duction and western blot in Text S1 in Additional file 1.
The following primary antibodies were used at the stated
dilutions: aH3K27me3 (Merck-Millipore; cat: 07-449;
1:1000); aH3K4me3 (Merck-Millipore; cat: 07-473;
1:1000); aH3 (Abcam, Cambridge, UK; cat: ab1791;
1:1000); aEzh2 (Merck-Millipore; cat: 17-662; 1:1000);
aSuz12 (Cell Signaling Technology, Beverly, MA, USA;
cat: D39F6#3737S; 1:1000); aEed (Merck-Millipore; cat:
05-1320; 1:5000); aActb (Abcam; cat: ab3280; 1:5000).
DNA methylation analyses
Quantitation of methyl-cytosine in genomic DNA by HPLC
was performed as previously described [61] with the follow-
ing alterations. To improve peak resolution, the column
was chilled to 8°C. Deoxyribonucleotides were detected
using a Dionex 3000 multiple wavelength detector at their
extinction maxima: dCMP (deoxycytosine monopho-
sphate), 276 nm; 5mdCMP (5’-methyl-deoxycytosine
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monophosphate), 282 nm. Quantifications were calculated
from the area under each peak using the respective
extinction coefficients (dCMP, 8.86 × 103; 5mdCMP, 9.0 ×
103). RRBS was performed by BaseClear (Leiden, The Neth-
erlands) as provided by the ‘Epiquest Genome-wide Basic
Service’. HELP-tag-seq was performed as previously
described [62-64] using a custom mouse MspI library.
Bisulfite sequencing was performed as described in Text S1
in Additional file 1. Primers used for bisulfite sequencing
are shown in Table S1 in Additional file 1.
Gene expression assays
Total RNA was isolated from cells and tissues in triplicate
using Trizol (Life Technologies, Invitrogen) according to
the manufacturer’s instructions. RNA integrity was deter-
mined by agarose gel electrophoresis and/or Bioanalyser
RNA6000 Nano chip (Agilent, Santa Clara, CA, USA).
Only RNA with an RNA integrity score >9 was used.
qRT-PCR was performed as described in Text S1 in Addi-
tional file 1. qRT-PCR primers are shown in Table S1 in
Additional file 1. For Illumina BeadChip expression micro-
arrays, RNA was amplified using a TotalPrep RNA ampli-
fication kit (Life Technologies, Ambion) and analyzed on
Illumina (San Diego, CA, USA) MouseWG-6 v2.0 Expres-
sion BeadChips (hybridization and scanning performed by
the Genetics Core at the Wellcome Trust Clinical
Research Facility, Edinburgh, UK). For mRNA-seq,
libraries were generated using the Illumina strand-
specificity protocol [65], and sequenced using 50 bp
single-end sequencing on an Illumina HiSeq2000
sequencer (performed by Ambry Genetics).
Data analysis
For the methods used in the normalization and analysis of
data from ChIP-chip, ChIP-seq, RRBS, HELP-tag-seq,
Illumina BeadChip expression microarray, and mRNA-seq
see Text S1 in Additional file 1.
Data access
Raw and processed data are deposited into the Gene
Expression Omnibus (GEO accession number: GSE44278).
Additional material
Additional file 1: A PDF document containing supplemental files for
this paper. Included are eight supplemental figures (Figures S1 to S8),
supplemental materials and methods (Text S1), and two supplemental
tables (Tables S1 and S2).
Additional file 2: An Excel spread sheet (XLS) showing normalized
average enrichments and P-values observed at gene promoter regions
by ChIP-chip for H3K27me3 and H3K4me3 in Dnmt1+/+ and Dnmt1-/-
MEFs.
Additional file 3: An Excel spread sheet (XLS) showing genomic
windows (100 kb) that show differential H3K27me3 by ChIP-seq in
Dnmt1+/+ and Dnmt1-/- MEFs, along with the number of H3K27me3
reads overlapping each window in each sample and their odds ratios.
Additional file 4: An Excel spread sheet (XLSX - compressed in ZIP)
showing genomic windows (1 kb) that show differential H3K27me3 by
ChIP-seq in Dnmt1+/+ and Dnmt1-/- MEFs, along with the number of
H3K27me3 reads overlapping each window in each sample and their
odds ratios.
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